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Abstract
Background: The diagnostic pathway of Parkinson’s disease (PD) is often complicated. Experiences during this
pathway can affect patients’ satisfaction and their confidence and trust in healthcare providers. Although healthcare
providers cannot influence the impact of the diagnosis, they can influence how patients experience the pathway.
This study, therefore, aims to provide insight into PD patients’ dissatisfaction with the diagnostic pathway and to
describe the factors that influence it.
Methods: We carried out a cross-sectional survey study among 902 patient members of the Dutch Parkinson’s
Disease Association, who were each asked to write an essay about their diagnostic pathway. A coding format was
developed to examine the content of these essays. Inter-observer agreement on coding patient dissatisfaction was
calculated using Cohen’s kappa. The χ2 test and a multivariable logistic regression analysis were performed to assess
the relation between dissatisfaction and sex, level of education, duration of the pathway, communication with the
general practitioner (GP) and the neurologist, the number of healthcare providers involved, whether or not a
second opinion had taken place (including the person who initiated it) and diagnostic delay (taking into
consideration who caused the delay according to the patient). A subgroup analysis was performed to gain insight
into sex-related differences.
Results: Of all patients, 16.4% explicitly described they were dissatisfied with the diagnostic pathway, whereas 4.8%
were very satisfied. The inter-observer agreement on coding dissatisfaction was κ = 0.82. The chance of dissatisfaction
increased with a lower level of education, the involvement of more than one additional healthcare provider, a second
opinion initiated by the patient and delay caused by a healthcare provider. When only the GP and the neurologist
were involved, women were more likely to be dissatisfied than men.
Conclusions: PD patients’ dissatisfaction with the diagnostic pathway is related to a lower level of education, a second
opinion initiated by the patient and experienced diagnostic delay. GPs can positively influence patients’ experiences if
they are aware of these risk factors for dissatisfaction and pay extra attention to communication and shared decision
making. This will contribute to a trusting therapeutic relationship that is indispensable with progression of the disease.
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Background
Patients’ experiences during the pathway to a diagnosis
can be negative and have long-term consequences.
Research in cancer patients shows that patients tend to
lose confidence and trust in their general practitioner
(GP) if the nature of the presented symptoms is not im-
mediately recognised by the GP and if multiple visits to
the GP are necessary before referral takes place [1–3].
Moreover, patients may interpret the need to consult their
GP repeatedly as lack of responsiveness and thus as delay
caused by the GP, resulting in patient dissatisfaction [4].
Diagnosis timing issues may induce patients to change
general practice [5]. The importance of timeliness of
diagnosis related to patient dissatisfaction emerges from
a study amongst cancer patients, showing that patients
suffering from cancer types that are difficult to recog-
nise, such as ovarian cancer and multiple myeloma, are
more likely to change practice than patients with types
of cancer that are easier to recognise, such as melanoma
and breast cancer [5]. In addition, long-term care experi-
ences of cancer patients are worse for those who visited
their GP several times before they were referred than for
those who were referred instantly [2].
Parkinson’s disease (PD) is a progressive neurodegen-
erative disorder that can be difficult to diagnose [6].
Classic symptoms such as muscular rigidity and tremor
are not always present and may be preceded by a variety
of motor and non-motor symptoms that are not neces-
sarily disease-specific [7–10]. When patients consult
their GP, symptoms are often still limited and embedded
in clinical uncertainty, while referral to the neurologist
takes place later in the disease trajectory [10–12]. This
may explain the difficulties GPs encounter in recognis-
ing PD as the common cause of these symptoms and in
referring accordingly [10, 12]. As a consequence, the
pathway to the diagnosis of PD can be lengthy and
uncertain and, unless well explained, it is reasonable to
expect a negative influence on patient confidence, trust
and satisfaction [6, 13].
Although the impact of a PD diagnosis cannot be
taken away completely, healthcare providers can have an
influence on how patients experience the diagnostic
pathway. It is known that PD patients’ dissatisfaction
with the way the diagnosis of PD is explained to them
has an impact on health-related quality of life [14]. Lack
of involvement in therapy decisions is also negatively re-
lated to satisfaction and compliance with therapy [15].
However, research into patient experiences of the diag-
nostic pathway of PD is limited and does not provide
any insight into factors influencing patient dissatisfaction
[13, 16]. Patients will benefit from a sustained trusting
relationship with their GPs, in which they have confi-
dence in the personal care provided by the GP, as pro-
gression of the disease will inevitably cause health
problems that require the GP’s involvement [17]. In
order to optimise patients’ experiences of the pathway to
the diagnosis of PD and, hence, to contribute to a trust-
ing patient-doctor relationship, this study aims to im-
prove our understanding of PD patients’ dissatisfaction
with the diagnostic pathway and to describe the factors
influencing it.
Methods
Recruitment and data collection
We conducted a cross-sectional survey study among
patient members of the Dutch Parkinson’s Disease
Association. All members with a known email address
(n = 4717) were approached digitally to enlist their
participation. Patients were asked to fill in their
demographic characteristics at the time of diagnosis:
sex, age, highest level of education finished, employ-
ment status and civil status. They were also asked to
describe their experiences of the pathway from the
first recognisable symptom(s) to the diagnosis of PD.
To facilitate patients in formulating their essay, we
provided them with a number of guiding questions
that were based on the literature and expert opinion
and had been tested in a pilot study (Table 1). In case
patients had questions, concerns or hesitations, they
could contact the researcher (AP). After finishing
their essays, patients had to agree to submission, a
step that was assessed as informed consent. Participa-
tion was one-time only, voluntarily and anonymous.
The research ethics committee of the Radboud
university medical center examined the protocol of
the study and concluded that the study could be
carried out in the Netherlands without needing
approval by the regional research ethics committee.
A qualitative analysis of a purposive sample of 52
essays preceded this study. Purposive sampling was
based on the collected demographic characteristics at
the time of diagnosis. We refer to the paper describing
the qualitative analysis for more detailed information on
recruitment, data collection and results [16]. The
Table 1 Questions guiding patients to describe their
experiences of the diagnostic pathway of Parkinson’s disease
Question
1. Can you describe the first symptom(s) that eventually turned
out to be a forerunner sign of PD? What did you do when
you experienced this symptom or these symptoms?
2. Can you describe what happened next, until the
moment you were diagnosed with PD?
3. What role was there for people in your surroundings
during the diagnostic pathway?
4. Looking back on the diagnostic pathway, how do you feel
about the timing of the diagnosis? Can you describe the
consequences of this timing for you and your family?
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qualitative analysis results were used to create a format
to examine the content of all essays. Details on the
coding format are described in Additional file 1.
Though patient dissatisfaction with the diagnostic
pathway was the main focus of the current study,
patients were not explicitly asked for their satisfaction or
dissatisfaction. Rather, we encouraged them to describe
their feelings about the timing of the diagnosis and the
consequences of this timing in order to gain insight into
patients’ spontaneous reporting of the diagnostic path-
way (Table 1). We only applied codes if patients spon-
taneously and unmistakably expressed their satisfaction
or dissatisfaction: ‘satisfied’ was coded when patients
were clearly positive, and ‘dissatisfied’ was coded when
patients explicitly mentioned problems or made negative
remarks. All other cases, including the expression of
mixed emotions, were coded ‘neutral’. To enable the re-
searchers to interpret satisfaction and dissatisfaction
with the diagnostic pathway, it was defined as ‘the over-
all feeling a patient expressed about the diagnostic path-
way in his/her essay’, and it was independently coded by
two researchers (AP, OdB) in a random sample of 225
essays (25%) to enable calculation of inter-observer
agreement.
The same researchers also independently coded 154
essays (17.1%) completely, initially to create consensus
on the coding method, and later to discuss doubts in
coding. The other 748 essays were coded by one
researcher (OdB). Codes were only applied if patients in
their essay explicitly described the duration of the path-
way, communication with the GP or the neurologist, the
number of different healthcare providers involved, a
second opinion or experienced delay.
Data analysis
Statistical analyses were conducted using Statistical
Package for the Social Sciences (SPSS) 22.0. Descriptive
statistics were calculated. As patient dissatisfaction was
the main focus of our analysis, the expressed feelings
were divided into two categories: dissatisfied and
neutral/satisfied. Cohen’s kappa was used to calculate
inter-observer agreement.
We wanted to assess the relation between dissatisfac-
tion with the diagnostic pathway and a selection of
factors. These factors were selected based on literature
[5, 18], the results of the preceding qualitative analysis
[16] and expert opinion. The χ2 test was used to assess
the relation between dissatisfaction and the demographic
variables sex and level of education, the latter divided
into low (primary school/vocational education), medium
(secondary school) and high (higher professional educa-
tion/university). Moreover, we assessed the relation be-
tween dissatisfaction and duration of the diagnostic
pathway (divided into unknown, <2 years or ≥2 years on
the basis of the literature [6, 8, 9]); communication with
the GP or the neurologist (negative, neutral/positive);
and the number of different healthcare providers
involved (0, 1, 2, ≥3). As guidelines in the Netherlands
describe the involvement of a GP and a neurologist as
usual care in the pathway to the diagnosis of PD, these
healthcare providers were excluded from the number of
healthcare providers involved [11, 19].
In addition, we performed the χ2 test to assess the
relation between dissatisfaction and second opinion.
Second opinion was defined as ‘the involvement of a sec-
ond neurologist during the pathway towards the diagno-
sis of PD’ and was categorised into: no second opinion/
not mentioned; second opinion on the patient’s initiative
(including the combined initiative of patient and health-
care provider); and second opinion on the healthcare
provider’s initiative. We also assessed the relation
between dissatisfaction and experienced diagnostic delay,
taking into consideration who caused the delay accord-
ing to the patient. Delay was divided into: no delay; not
(clearly) mentioned; caused by the patient (including
caused by both the patient and the healthcare provider);
caused by the healthcare provider(s); and unknown who
caused it.
A multivariable logistic regression analysis was per-
formed to assess the independent association between
dissatisfaction and sex, level of education, duration of
the diagnostic pathway, the number of different
healthcare providers involved, second opinion and
experienced delay. As only few patients explicitly
described their communication with the GP and the
neurologist, this factor was excluded from the regres-
sion analysis. We also excluded second opinions if it
was unknown on whose initiative they had taken
place. As the literature shows that female patients
tend to be more dissatisfied with care than male pa-
tients [18], we also performed a subgroup analysis to
gain insight into possible sex-related differences.
Therefore, we added interaction terms of sex with the
other variables to the multivariable regression model.
A P-value less than 0.05 was considered statistically
significant.
Results
Characteristics of the study population
Of all patient members who received an email, 27%
started and 21% finished the essay. Seventy-two essays
were excluded due to incorrect or uncertain diagnosis of
PD or a complete lack of information. Finally, 902 essays
were included in this study (Fig. 1). More men than
women participated, and most patients had a high level
of education (Table 2). Mean age at the time of diagnosis
was 60 years (Standard Deviation (SD) 9.9).
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Patient dissatisfaction with the diagnostic pathway
The inter-observer agreement of the two researchers
(AP, OdB) on coding patient dissatisfaction with the
diagnostic pathway was κ = 0.82 (95% Confidence
Interval (CI) 0.72–0.91).
More than one in seven patients (n = 148; 16.4%)
explicitly described they were dissatisfied with the expe-
rienced diagnostic pathway. Most patients (n = 711;
78.8%) did not clearly express their opinion, while less
than 5 % (n = 43; 4.8%) mentioned they were satisfied.
Dissatisfaction was significantly associated with several
factors. Female sex (P < 0.01), duration of the pathway
(P < 0.001), communication with the GP or the
neurologist (P < 0.001 and P < 0.01, respectively), the
number of healthcare providers involved (P < 0.001),
second opinion (P < 0.001) and experienced delay (P <
0.001) increased the chance of dissatisfaction (Table 3).
Of the patients who felt the healthcare provider caused
delay, more than half were dissatisfied (n = 111; 61.0%),
whereas less than 5% of the patients, who did not ex-
perience delay or felt delay was due to themselves, were
dissatisfied (n = 15; 3.2% and n = 2; 2.6%, respectively).
The multivariable analysis showed that low-educated
patients were more likely to be dissatisfied than medium
and high-educated patients (Odds Ratio (OR) 0.45; CI
0.2–0.9 and OR 0.46; CI 0.2–0.9, respectively). The
Fig. 1 From recruitment of patient members of the Dutch Parkinson’s Disease Association to essays included
Table 2 Included PD patients’ characteristics at the time of diagnosis
Demographic variable n = 902 (100%)
Sex Male 550 (61.0%)
Female 352 (39.0%)
Mean age in years (SD) 60.1 (9.9)
Level of education Low 250 (27.7%)
Medium 284 (31.5%)
High 368 (40.8%)
Employment status Employed 352 (39.0%)
Self-employed 71 (7.9%)
Retired 307 (34.0%)
Recipient of sickness benefits 18 (2.0%)
Unemployed 86 (9.5%)
Combination of employments/other 68 (7.5%)
Civil status Single a 80 (8.9%)
With partner 596 (66.1%)
With family (including partner) 217 (24.1%)
Other 9 (1.0%)
aIncluding widowed and divorced
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chance of dissatisfaction was also significantly higher
when more than one additional healthcare provider was
involved. With the involvement of two extra healthcare
providers, the odds ratio for patient dissatisfaction was
2.53 (CI 1.2–5.3) compared to a situation in which only
the GP and the neurologist were involved. If three or
more additional healthcare providers were involved, the
odds ratio for dissatisfaction was even higher (OR 3.92;
CI 1.4–10.7). A second opinion on the patient’s initiative
increased the chance of dissatisfaction compared to
cases without a second opinion (OR 5.04; CI 2.3–10.9).
In addition, when patients experienced delay caused by a
healthcare provider, they were significantly more likely
to be dissatisfied than patients who did not experience
delay (OR 38.78; CI 20.0–75.0) (Table 4).
Men and women significantly differed in the relation be-
tween dissatisfaction with the diagnostic pathway and the
number of healthcare providers involved during this path-
way. If only the GP and neurologist were involved, female
Table 3 Univariable analysis of factors influencing patient
dissatisfaction with the diagnostic pathway of Parkinson’s disease
Variable Patient
dissatisfaction
n (%)
Patient
satisfaction/
neutral n (%)
P value
Sex (n = 902) <0.01*
Male 74 (13.5%) 476 (86.5%)
Female 74 (21.0%) 278 (79.9%)
Level of education (n = 902) 0.22
Low 49 (19.6%) 201 (80.4%)
Medium 40 (14.1%) 244 (85.9%)
High 59 (16.0%) 309 (84.0%)
Duration of the diagnostic pathway (n = 902) <0.001*
Unknown 54 (13.3%) 352 (86.7%)
< 2 years 28 (12.1%) 204 (87.9%)
≥ 2 years 66 (25.0%) 198 (75.0%)
Communication with the general practitioner (n = 77) <0.001*
Negative 40 (69.0%) 18 (31.0%)
Neutral/positive 2 (10.5%) 17 (89.5%)
Communication with the neurologist (n = 78) <0.01*
Negative 41 (62.1%) 25 (37.9%)
Neutral/positive 1 (8.3%) 11 (91.7%)
Number of healthcare providers involved (n = 902)a <0.001*
0 43 (8.2%) 484 (91.8%)
1 52 (21.3%) 192 (78.7%)
2 31 (34.8%) 58 (65.2%)
≥ 3 22 (52.4%) 20 (47.6%)
Second opinion (n = 856)b <0.001*
No/not mentioned 93 (12.5%) 650 (87.5%)
Yes, on the patient’s initiative 29 (45.3%) 35 (54.7%)
Yes, on the healthcare
provider’s initiative
12 (24.5%) 37 (75.5%)
Experienced delay (n = 902) <0.001*
No delay 15 (3.2%) 454 (96.8%)
Not (clearly) mentioned 9 (6.8%) 124 (93.2%)
Yes, caused by the patient 2 (2.6%) 74 (97.4%)
Yes, caused by a healthcare
provider
111 (61.0%) 71 (39.0%)
Yes, unknown who caused it 11 (26.2%) 31 (73.8%)
*Statistically significant, P < 0.05
aExcluding GP and neurologist
bExcluding second opinion, initiative unknown
Table 4 Multivariable logistic regression of factors influencing
patient dissatisfaction with the diagnostic pathway of Parkinson’s
disease
Variable
(n = 856)b
Odds ratio (OR)
for dissatisfaction
95% Confidence
Interval (CI)
P value
Sex 0.12
Male Reference
Female 1.50 0.9–2.5 0.12
Level of education 0.02*
Low Reference
Medium 0.45 0.2–0.9 0.02*
High 0.46 0.2–0.9 0.01*
Duration of the diagnostic pathway 0.47
Unknown Reference
< 2 years 1.20 0.6–2.4 0.61
≥ 2 years 1.43 0.8–2.5 0.22
Number of healthcare providers involveda 0.01*
0 Reference
1 1.66 0.9–3.0 0.09
2 2.53 1.2–5.3 0.01*
≥ 3 3.92 1.4–10.7 <0.01*
Second opinion <0.001*
No/not mentioned Reference
Yes, on the patient’s
initiative
5.04 2.3–10.9 <0.001*
Yes, on the healthcare
provider’s initiative
2.11 0.8–5.4 0.12
Experienced delay <0.001*
No delay Reference
Not (clearly) mentioned 1.85 0.7–4.6 0.19
Yes, caused by
the patient
0.84 0.2–4.0 0.83
Yes, caused by a
healthcare provider
38.78 20.0–75.0 <0.001*
Yes, unknown
who caused it
7.14 2.7–19.0 <0.001*
*Statistically significant, P < 0.05
aExcluding GP and neurologist
bExcluding second opinion, initiative unknown
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patients were more likely to be dissatisfied than male pa-
tients (OR 3.11; CI 1.4–7.0). There were no significant dif-
ferences between men and women in the chance of
dissatisfaction with the involvement of one or more add-
itional healthcare provider(s) (OR 0.58; CI 0.2–1.4 with
one, OR 1.63; CI 0.4–5.8 with two, and OR 1.92; CI 0.3–
12.1 with three or more healthcare providers involved).
No interaction effects were found for any other variables
(results provided in Additional file 2).
Discussion
Most patients in our study do not describe dissatisfac-
tion with the diagnostic pathway of PD. However, more
than one in seven patients is explicitly dissatisfied. The
chance of dissatisfaction is increased with a lower level
of education, the involvement of more than one
additional healthcare provider, a second opinion on the
patient’s initiative and delay caused by the healthcare
provider. In addition, if only the GP and neurologist
have been involved in the diagnostic pathway, women
are more likely to be dissatisfied than men.
Although dissatisfaction with the diagnostic pathway
of PD appears to be playing a limited role in quantitative
terms, dissatisfaction with the initial diagnostic process
can have an impact on long-term care, stressing the im-
portance of paying attention to it: cognitions formed at
an early stage tend to determine care experiences during
the further treatment episode [2, 5, 20].
Our study shows that it is not the duration of the diag-
nostic pathway of PD on its own that leads to patient
dissatisfaction, but that other factors appear to be im-
portant as well. In line with the literature, the women in
our study are more likely to be dissatisfied than the men
[5, 18]. Contrary to what we expected, however, the
chance of dissatisfaction is highest for low-educated pa-
tients [5, 18]. As only few patients in our study explicitly
mention their communicative experiences with the GP
and the neurologist, we could not demonstrate an inde-
pendent association between dissatisfaction and commu-
nication. It is likely, though, that communication at least
partly explains the finding that low-educated patients
are more often dissatisfied than patients with higher
education as low-educated PD patients are known to
have a lower level of health literacy than high-educated
patients and a low level of health literacy negatively in-
fluences patients’ ability to obtain and understand infor-
mation about a disease [21, 22].
In the case of PD, the complexity and abstractness of
the process in the brain that causes the complaints and
the varying expression of the disease can be difficult for
a doctor to explain understandably and challenging for a
patient to grasp fully. An earlier study shows that the
way the diagnosis of PD is communicated to a patient is
very important [13]. Moreover, the difficulty for GPs to
recognise PD and the fact that a diagnosis is not 100%
certain until autopsy is performed are likely to influence
patients’ experiences of the diagnostic pathway of PD as
well [10, 17]. Cancer patients, for example, mention they
feel uncertain and anxious if referral is not explained
carefully, and patients with amyotrophic lateral sclerosis
report falsely raised hopes after every negative investiga-
tion [20, 23]. Our study shows that patients who feel
that their healthcare provider is responsible for delay in
the diagnostic pathway are far more likely to be dissatis-
fied than patients who do not describe delay.
Lack of communication during the diagnostic pathway
is also known to have a long-term impact on the
patient-doctor relationship, a relationship that depends
on patients’ satisfaction and their confidence and trust in
the healthcare provider - with the risk of disappointment
as the distinguishing feature between the latter two: in a
situation of trust one is more likely to be disappointed-
[20, 24]. In our study, patient dissatisfaction is related to
a second opinion on the patient’s initiative. Although we
do not know whether dissatisfaction is the cause or the
result of the patient’s request for a second opinion, earl-
ier research shows that dissatisfaction is negatively asso-
ciated with trust and that trust limits the tendency for
patients to request for a second opinion [24]. Physicians
who listen carefully, behave empathically and communi-
cate clearly are more likely to be trusted by their pa-
tients [24, 25]. Moreover, trust is further enhanced if
patients feel they are treated as equal partners [24, 25].
Though the negative impact of being diagnosed
with PD cannot be ruled out, GPs can contribute to
their patients’ experiences of the diagnostic pathway
of PD in a positive way by using their central role in
symptom recognition and referral to communicate
openly about the clinical uncertainty involved in PD
diagnosis and about the expectations of referral, while
taking into account a patient’s level of health literacy
and offering scope for questions, hesitations and emo-
tions. This is how GPs and patients can go through
the diagnostic pathway of PD together and make
shared decisions whenever possible or desirable. It is
likely that such an experience will contribute to pa-
tient satisfaction with the pathway and will help to
maintain a trusting therapeutic relationship that is in-
dispensable with progression of the disease [17].
Strengths and limitations of the study
To the best of our knowledge, this is the first study
that reports on patient dissatisfaction with the diag-
nostic pathway of PD and factors that might be of in-
fluence. We included a large number of essays.
Moreover, we used an original approach to mixed
methods research [26]. Our data are based on
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patients’ spontaneous reporting, thus reflecting what
matters most to them, rather than reflecting their rec-
ognition of pre-determined items.
We used a coding format that was based on the results
of our preceding qualitative study, and a considerable
part of all essays was independently coded by two re-
searchers, who reached consensus in case of coding dis-
agreement [16]. The strength of the inter-observer
agreement on coding dissatisfaction can be considered
‘almost perfect’, confirming our opinion that we used a
reliable method to extract the content of the essays [27].
We feel confident that the results of our study provide
valuable new information that can be used to improve
patient experiences of the diagnostic pathway of PD.
Nevertheless, there are limitations to consider when
interpreting the results of this study. As patients de-
scribed their experiences retrospectively, recall bias can-
not be ruled out. In addition, this study used the
diagnostic pathway of PD as a starting-point, yet patients
are likely to have had previous care experiences with
their GPs, and their satisfaction or dissatisfaction with
these earlier care episodes may have influenced their ex-
periences with the diagnostic pathway of PD as well as
their description of it. In addition, dissatisfaction with
the pathway cannot solely be interpreted as dissatisfac-
tion with the GP, as more healthcare providers have
likely been involved in the diagnostic process. The spon-
taneous reporting method does not allow for interpret-
ation of causality and if information on a second opinion
is lacking, for example, it may not have been performed
or it may not have been reported.
For practical reasons, we chose to approach only those
PD patients in the Netherlands who are members of the
Dutch Parkinson’s Disease Association, and not all pa-
tients we approached finalised their essay. As information
on the non-responders and the patients who did not finish
their essay is lacking, selection bias cannot be ruled out.
As a possible result of our decision to use a digital ap-
proach, the patients included in our study are relatively
young, and it cannot be ruled out that this unequal distri-
bution has influenced the results as well, as younger pa-
tients are generally known to be less satisfied [18].
Conclusions
The diagnostic pathway of PD can be lengthy and uncer-
tain, and more than one in seven PD patients is clearly
dissatisfied with it. This study shows that patient dissat-
isfaction is related to a lower level of education, a second
opinion on the patient’s initiative and delay that is
caused by the healthcare provider according to the pa-
tient. GPs can positively influence their patients’ experi-
ences if they are more aware of these risk factors for
dissatisfaction and pay extra attention to open commu-
nication on the clinical uncertainties of the early
symptoms of PD and on shared decision making on re-
ferral. This is likely to contribute to a trusting relation-
ship between PD patients and their GPs, a relationship
that is essential at all stages of the disease.
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